TY - JOUR A1 - Fruscalzo, Arrigo A1 - Frommer, Julia-Marie A1 - Londero, Ambrogio P. A1 - Henze, Andrea A1 - Schweigert, Florian J. A1 - Nofer, Jerzy-Roch A1 - Steinhard, Johannes A1 - Klockenbusch, Walter A1 - Schmitz, Ralf A1 - Raila, Jens T1 - First trimester TTR-RBP4-ROH complex and angiogenic factors in the prediction of small for gestational age infant’s outcome JF - Archives of gynecology and obstetrics N2 - To study the role of the TTR-RBP4-ROH complex components (transthyretin, serum retinol binding protein, retinol) and of angiogenic factors PlGF (placental growth factor) and sFlt-1 (soluble fms-like tyrosine kinase-1) in pregnancies complicated by small for gestational age infants (SGA). Case control study conducted on maternal serum collected between 11 + 0 to 13 + 6 weeks of gestation. TTR, RBP4, ROH, PlGF and sFlt-1 were measured in SGA patients (birth weight < 10%) who delivered at term (n = 37) and before 37 weeks of gestation (n = 17) and in a matched control group with uneventful pregnancies (n = 37). We found decreased RBP4 in SGA patients that delivered fetuses < 3% and in fetuses delivered after the 37 weeks of gestation compared to controls [1.50 (95% CI 1.40-1.75) vs 1.62 (95% CI 1.47-1.98), p < 0.05]. Further, we found lower PlGF and sFlt-1 concentrations in SGA that delivered before 37 weeks of gestation compared to controls (respectively, PIGF and sFlt-1: 39.7 pg/ml (95% CI 32.3-66.3) vs 62.9 pg/ml (95% CI 45.2-78.4) and 906 pg/ml (95% CI 727-1626) vs 1610 pg/ml (95% CI 1088-212), p < 0.05). First trimester maternal serum RBP4 and angiogenic factors PlGF and sFlt-1 can differently predict the timing of delivery of pregnancies complicated by SGA fetuses. KW - Low birth weight KW - Small for gestational age KW - Pregnancy KW - First trimester KW - Marker KW - RBP4 KW - TTR KW - Retinol KW - Vitamin A KW - sFlt-1 KW - PlGF Y1 - 2017 U6 - https://doi.org/10.1007/s00404-017-4338-4 SN - 0932-0067 SN - 1432-0711 VL - 295 SP - 1157 EP - 1165 PB - Springer CY - Heidelberg ER - TY - JOUR A1 - Kwanbunjan, Karunee A1 - Panprathip, Pornpimol A1 - Phosat, Chanchira A1 - Chumpathat, Noppanath A1 - Wechjakwen, Naruemon A1 - Puduang, Somchai A1 - Auyyuenyong, Ratchada A1 - Henkel, Ina A1 - Schweigert, Florian J. T1 - Association of retinol binding protein 4 and transthyretin with triglyceride levels and insulin resistance in rural thais with high type 2 diabetes risk JF - BMC Endocrine Disorders N2 - Background: Retinol binding protein 4 (RBP4), a protein secreted by adipocytes and bound in plasma to transthyretin (TTR), has been associated with obesity, the early phase of insulin resistance, metabolic syndrome, and type 2 diabetes mellitus. The objective of this study was to elucidate the relationship between RBP4, TTR, triglyceride (TG) and type 2 diabetes risk in rural Thailand. Results: RBP4 and TTR levels, as well as homeostatic model assessment of insulin resistance (HOMA-IR) values, were significantly elevated among subjects with high triglyceride levels (p < 0.01, p < 0.05, p < 0.05, respectively). Triglyceride levels correlated with RBP4 (r = 0.34, p < 0.001) and TTR (r= 0.26, p < 0.01) levels, as well as HOMA-IR values (r= 0.16, p < 0.05). After adjustment for age and gender, the risk of hypertriglyceridemia was 3.7 times greater (95% Cl =1.42 -9.73, p = 0.008) in the highest RBP4 tertile as compared to the lowest tertile. Similarly, the highest TTR and HOMA-IR tertiles had greater risk of hypertriglyceridemia at 3.5 (95% Cl = 1.30-9.20, p = 0.01) and 3.6 (95% CI = 1.33- 9.58, p = 0.01) times higher than the respective lowest tertiles. The correlation between TTR and blood glucose was statistically significant (r 0.18, p < 0.05), but not found this relationship in RBP4. Conclusions: The associations of RBP4 and TTR with hypertriglyceridemia and insulin resistance may have important implications for the risk of heart disease and stroke. KW - RBP4 KW - TTR KW - HOMA-IR KW - Hypertriglyceridemia KW - Type 2 diabetes Y1 - 2018 U6 - https://doi.org/10.1186/s12902-018-0254-2 SN - 1472-6823 VL - 18 PB - BMC CY - London ER - TY - JOUR A1 - Schmiedchen, Bettina A1 - Longardt, Ann Carolin A1 - Loui, Andrea A1 - Buehrer, Christoph A1 - Raila, Jens A1 - Schweigert, Florian J. T1 - Effect of vitamin A supplementation on the urinary retinol excretion in very low birth weight infants JF - European journal of pediatrics : official organ of the Belgian Pediatric Association N2 - Despite high-dose vitamin A supplementation of very low birth weight infants (VLBW, <1500 g), their vitamin A status does not improve substantially. Unknown is the impact of urinary retinol excretion on the serum retinol concentration in these infants. Therefore, the effect of high-dose vitamin A supplementation on the urinary vitamin A excretion in VLBW infants was investigated. Sixty-three VLBW infants were treated with vitamin A (5000 IU intramuscular, 3 times/week for 4 weeks); 38 untreated infants were classified as control group. On days 3 and 28 of life, retinol, retinol-binding protein 4 (RBP4), glomerular filtration rate, proteinuria, and Tamm-Horsfall protein were quantified in urine. On day 3 of life, substantial retinol and RBP4 losses were found in both groups, which significantly decreased until day 28. Notwithstanding, the retinol excretion was higher (P<0.01) under vitamin A supplementation as compared to infants of the control group. On day 28 of life, the urinary retinol concentrations were predictive for serum retinol concentrations in the vitamin A treated (P<0.01), but not in the control group (P=0.570). Conclusion: High urinary retinol excretion may limit the vitamin A supplementation efficacy in VLBW infants. Advanced age and thus postnatal kidney maturation seems to be an important contributor in the prevention of urinary retinol losses. KW - Vitamin A supplementation KW - RBP4 KW - Very low birth weight infant KW - Urine excretion Y1 - 2016 U6 - https://doi.org/10.1007/s00431-015-2647-9 SN - 0340-6199 SN - 1432-1076 VL - 175 SP - 365 EP - 372 PB - Springer CY - New York ER -